Skip to main content
. 2022 Oct 31;14(21):5373. doi: 10.3390/cancers14215373

Figure 3.

Figure 3

Luteolin and its derivatives. (A) 2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromen-4-one (B) Monoacylated luteolin (C) 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-chromene-4-thione.